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Centrosome Defects and Genetic Instability in Malignant Tumors1
German A. Pihan, Aruna Purohit, Janice Wallace, Hans Knecht, Bruce Woda, Peter Quesenberry, and
Stephen J. Doxsey2
Department nj Pathology Â¡C.A. P., J. W., B. WJ. Pro/tram in Molet-nlar Medicine Â¡A.P., S. J. D.I. and Cancer Center [H. K.. P. Q.Â¡. University i>f Massachusetts Medical
School. Worcester. Massachusetts 06510
ABSTRACT
Genetic instability is a common feature of many human cancers. This
condition is frequently characterized by an abnormal number of chromo
somes, although little is known about the mechanism that generates this
altered genetic state. One possibility is that chromosomes are missegre-
gated during mitosis due to the assembly of dysfunctional mitotic spindles.
Because ccntrosomes are involved in spindle assembly, they could con
tribute to chromosome missegregation through the organization of aber
rant spindles. As an initial test of this idea, we examined malignant tumors
for centrosome abnormalities using antibodies to the centrosome protein
l>rritrndin. We found that centrosomes in nearly all tumors and tumor-
derived cell lines were atypical in shape, size, and composition and were
often present in multiple copies. In addition, virtually all pericentrin-
staining structures in tumor cells nucleated microtubules, and they par
ticipated in formation of disorganized mitotic spindles, upon which chro
mosomes were missegregated. All tumor cell lines had both centrosome
defects and abnormal chromosome numbers, whereas neither was ob
served in nontumor cells. These results indicate that centrosome defects
are a common feature of malignant tumors and suggest that they may
contribute to genetic instability in cancer.
INTRODUCTION
Faithful segregation of chromosomes into daughter cells is es
sential for maintaining the genetic stability of most organisms.
Chromosome segregation is mediated by the mitotic spindle, which
has a complex structural organization and precisely timed move
ments that ensure the accuracy of this process (reviewed in Refs.
1-5). In normal cells, the metaphase spindle is a bipolar structure
comprised of microtubules that emanate from centrosomes at each
pole with chromosomes aligned at the spindle center (6. 7). Al
though it is not completely understood how spindles are assem
bled, the centrosome appears to play an important role in the
process (reviewed in Refs. 4 and 8). Spindle assembly and spindle-
mediated movements during chromosome segregation are con
trolled, in part, by cell cycle regulators. These include a system of
biochemical checkpoints, feedback controls, and degradation
events that ensure the stepwise progression of mitotic events and.
ultimately, the fidelity of chromosome segregation and the main
tenance of genetic stability (1-3, 9-11). Genetic instability is a
common feature of malignant tumors. It is frequently characterized
by an abnormal number of chromosomes, a condition known as
uneuploidy (12-14). Furthermore, recent results demonstrate that
aneuploid cells exhibit continuous changes in chromosome number
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throughout their lifetimes, suggesting that this CIN1 may contrib
ute to aneuploidy (15). These defects in chromosome number are
thought to occur through missegregation of chromosomes (1, 15),
but the mechanism by which this occurs has not been elucidated. It
is easy to envision how defects in mitotic spindle organization and
function could directly lead to chromosome missegregation (2, 3,
5, 16). Furthermore, because spindles are organized in part by
centrosomes (4, 8, 17), it is possible that abnormal centrosome
function could contribute to CIN. Support for this idea comes from
a recent observation suggesting that centrosome number is ampli
fied in genetically unstable cells mutant for the tumor suppressor
p53 (18).
Centrosomes are comprised of a pair of centrioles, the duplication
of which occurs once and only once during the normal cell cycle, and
the surrounding pericentriolar material, the substance involved in
microtubule nucleation (see Ref. 7). As an initial test of the idea that
centrosome dysfunction may lead to chromosome missegregation
through the organization of aberrant mitotic spindles, we examined
centrosomes in malignant tumors and cell lines derived from tumors.
We found that centrosomes immunolabeled with antibodies to peri-
centrin (19) were abnormal in structure, number, and function in a
wide range of malignant tumors and tumor cell lines. Furthermore,
tumor cell lines with abnormal centrosomes exhibited spindle abnor
malities and high levels of CIN.
MATERIALS AND METHODS
Preparation of Archival Tissues. Archival tissue consisted of paraffin-
embedded biopsy material fixed for 4-24 h in 10% formaldehyde in PBS.
Samples used in this study were 2 weeks to 4 years old. Five-mm-thick tissue
sections were cut on a conventional microtome used for paraffin-embedded
tissue sectioning. Sections were floated on a water bath kept at 37Â°C,picked
up on glass slides, allowed to air-dry, and baked at 60Â°Covernight. Sections
were deparaffini/ed in xylenes (twice for 3 min each at room temperature) and
placed in 100% ethanol. Sections were rehydrated in a descending gradient of
ethanol-water to 70% ethanol. transferred to PBS. and kept at 4Â°Cuntil
immunostaining (see below).
Preparation of Cells from Fresh Tissues by Collagenase/DNase Diges
tion. Cell suspensions were prepared from surgical resection specimens of
carcinomas and sarcomas by removing small samples (5 mm1) and mincing
with a ra/or blade in PBS at room temperature. Minced tissue was washed in
PBS and resuspended on an I-ml aliquot of fresh PBS containing 1.0 unit/ml
collagenase (Sigma Chemical Co.) and 0.1 unit/ml of DNase I (Sigma; Ret.
20). Tissue was rotated end-over-end for 2 h at room temperature. Samples
were then strained in a 100-mni nylon filter (Nytex: Small Parts, Inc.). Cells
were pelleted and washed in PBS by sequential centrifugation at 325 x g and
then cytospun onto slides.
Cytospinning of Cells onto Slides. Suspension cells were collected by
various methods (see below). Approximately 2 X 10s cells were resuspended
in 100 ml of PBS at room temperature and placed in a cytospin funnel(Shandon. Inc.). Cytot'unnels were attached to slides and spun at room tem
perature for 5 min at 65 rpm in a clinical cytocentrifuge (Cytp 2: Shandon.
Inc.). Cells on slides were fixed, processed, and mounted as described below.
1The abbreviations used are: CIN. chromosomal instability: DAP1. 4'.6-diamidino-2-
phenylindole: HD. Hodgkin's disease: pen/strep. 100 units/ml penicillin-0.1 mg/ml strep
tomycin: FISH, fluorescence in situ hybridi/ation: MT()C. microtubule organi/ing center.
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Antibodies. Antibodies to pericentrin (5 mg/ml. rabbit polyclonul) and
a-tubulin (2 mg/ml, mouse monoclonal) were used as described (19, 21). To
label spindles, we mixed antibodies to both proteins and incubated them with
different secondary antibodies (Jackson ImmunoResearch Laboratories). DNA
was visualized by staining with DAPI (Sigma).
Cell Lines. Tumor-derived cell lines were grown on coverslips (19) or
fixed in formalin, embedded in paraffin, and sectioned. Most cell lines were
obtained from American Type Culture Collection and grown as described.
L428, KHM2. and JC are HD cell lines. They were obtained from the German
Collection of Microorganisms and Cell Cultures (L428 and KHM2) and from
an immunocompromised patient with a HD-like lymphoma (JC; grown in our
laboratory). Bl 15 and B218 are early-passage EBV-transformed lymphoblas-
toid B-cell lines from peripheral blood B lymphocytes (gift of J. Sullivan.
University of Massachusetts Medical School, Worcester. MA). All lines listed
above were grown in RPMI (Hyclone Laboratories). 20% FCS. and pen/strep.
Breast carcinoma cell lines MDA-MB-436 and MDA-MB-157 were grown in
Leibovitz L-15 medium with 20% FCS. insulin (0.25 units/ml), glucose (45
mg/ml). and pen/strep; BT-549 and HS578T were grown in RPMI 1640 with
10% FCS-pen/strep. The prostate cell line PC-13 was grown in RPMI with
10% FCS-pen/strep. Colon carcinoma cell lines HT-29 and Lovo were grown
in McCoy's 5A medium with 10% FCS-pen/strep. All other cell lines above
were grown in RPMI with 20% FCS-pen/strep (American Type Culture
Collection).
Imitiunoperoxidase Labeling of Tissues and Cells for Centrosomes.
Sections or cells on slides were pressure-heated in antigen retrieval solution ( 1
HIMEDTA in water) in a microwaveable pressure cooker (Nordic Ware) for 20
min. allowed to cool to room temperature, and transferred to PBS (22). Slides
were immersed in 3% H202 in PBS for 15 min to block endogenous peroxidase.
Cells were then blocked in 2-nitro-5-thiobenzoate blocking buffer (TSA-
Indirect kit; NEN Life Science Products) for 1 h, followed by standard indirect
immunohistochemistry. Briefly, pericentrin antibody was diluted 1:1000 in
TBB (See TSA-Indirect kit) and added to slides in 100-ml aliquots for l h at
room temperature. Slides were washed in TNT (See NEN Life Science Prod
ucts kit) 3 times for 5 min each. Biotinylated secondary antibody against rabbit
immunoglobulins (Ventana Medical Systems) diluted 1:1000 was applied for
l h and incubated as above. Slides were washed in TNT 3 times for 5 min each.
Signals were amplified by catalyzed reporter deposition Tyramine signal
amplification (Ref. 23; TSA-Indirect kit), following manufacturer's instruc
tions. Slides were washed in TNT. counterstained in hematoxylin, and
mounted in Permount (Sigma), as described by manufacturer.
Immunofluorescence Labeling of Tissues and Cells. Cells were grown
on 12-mm glass coverslips or cytospun onto glass slides. Cells were washed in
PBS by placing coverslips into 12-well plates (Costar) with 1-2 ml of PBS or
by immersing slides in Coplin jars filled with PBS. Cells were permeabili/.ed
to release soluble proteins and better visualize centrosome staining (19). PBS
was then aspirated, and permeabilization buffer [80 HIMPIPES (pH 6.8). 5 mM
EGTA. 1 niM MgCU, and 0.5% Triton X-100] was added to plates or Coplin
jars and incubated tor 60 s at room temperature. Coverslips or slides were
transferred to new container/plate with -20Â°C methanol and incubated for 5
min. Samples were sometimes stored for days in methanol at â€”¿20Â°C.Cells
were washed 5 times in PBS by replacing half of the volume and aspirating
half of the volume. Blocking solution ( 1X PBS, 0.5% Triton X-100, and 2%
BSA) was added, and cells were incubated for 10 min. Coverslips or slides
were prepared for immunofluorescence microscopy as described (19). Immu
nofluorescence images were recorded on a Zeiss Axiophot using a X 100
objective on a Xillix charge-coupled device camera with a Kodak (KAF 1400)
chip and then pseudocolored and merged using ITEX-IPL software. Immu-
noperoxidase images were recorded using X60 and X100 objectives in real
color on an Olympus Vanox-S photomicroscope equipped with a Kodak CDS
460 digital camera.
Microtubule Nucleation and Centriole Labeling. To depolymerize and
regrow microtubules, cells were treated with nocodazole and washed free of
the drug as described (19, 21). To visualize centrioles, cells were treated with
nocodazole, permeabili zed with detergent (above) and processed for immuno
fluorescence using an a-tubulin antibody. Similar results were obtained with
an antibody that selectively stains the polymerized form of tubulin (tyrosi-
nated: gift of C. Bulinski. Columbia University).
FISH. Chromosome numbers were determined by FISH on interphase cells
using centromeric probes specific for chromosomes 1 and 8. labeled directly
with Spectrum Green (Vysis. Chicago, IL) or Spectrum Red as described
(15, 24). Evaluation of chromosome numbers by FISH rather than conven
tional metaphase analysis was used so that cells could be examined at all cell
cycle phases. Cells were grown on coverslips or cytospun onto glass slides,
permeabilized in detergent, and fixed as for centrosome immunofluorescence.
Probe hybridization and washes were as recommended by the manufacturer
(Vysis). Nuclei were counterstained by DAPI (20 ng/ml. Sigma) in PBS,
mounted (Vectashield, Vector Laboratories), and analyzed on a Zeiss epifluo-
rescence microscope equipped with a triple-band pass filter cube, allowing the
simultaneous visualization of Spectrum Green. Spectrum Red. and DAPI
signals. Centromeric signals appeared as discrete dots in most cells or as
elongated dots in cells presumed to be in the G: phase of the cell cycle. The
numbers of red and green signals per cell were determined in 1(X)-150 cells in
each cell line in two separate experiments.
RESULTS
Defects in Pericentrin Organization in Tumors. We examined
malignant tumors from a variety of tissues for the presence of
centrosome defects. These included primary tumors of the breast, pros
tate, lung, colon, and brain, as well as metastatic tumors of the breast,
lung, and colon. Tissue sections from archival formalin-fixed, paraffin-
embedded material were reacted with antibodies to the centrosome pro
tein pericentrin (19), and antibodies were detected by the amplified
immunoperoxidase technique (23). The pericentrin antibody used in this
analysis has been shown to specifically label centrosomes in a wide
variety of cell types when used in combination with the immunofluores-
cence technique (19). We confirmed that the antibody produced a similar
staining pattern by the immunoperoxidase technique in tissue sections
and cells in culture. In normal interphase cells, a single brown dot was
observed (the product of the immunoperoxidase reaction), and in mitotic
cells, a pair of dots was detected, one at each pole of the spindle.
When tumors were analyzed at low magnification by immu
noperoxidase staining, the tumor tissue could easily be delineated
from adjacent nontumor tissue by the significantly higher level of
pericentrin staining (Fig. 1). Higher magnification revealed that the
pericentrin staining was organized into structures that were abnor
mal in size, shape, and number (Fig. 2. Tumor tissues). Most tumor
cells had a single focus of pericentrin that was significantly greater
in diameter than centrosomes in nontumor cells (3-10-fold great
er). Tumor cells often had multiple pericentrin foci suggesting that
supernumerary centrosomes were present in these cells (see be
low). Multiple foci were detected in both paraffin sections [Fig. 2,
small arrowheads in A and D\ and freshly prepared samples (Fig.
3//) and were sometimes interconnected by atypical filaments of
pericentrin (Fig. IO, arrowheads). These structural defects oc
curred together with variable levels of diffuse and patchy pericen
trin material in the cytoplasm of tumor cells (Fig. 2, most panels).
The abnormal distribution of pericentrin staining seen in malignant
tumors was not observed in nontumor tissues. We examined over 12
cell types in tissues adjacent to tumors including cells of tumor origin,
resident cells in metastatic tumors, and cells in stroma, ducts, blood
vessels, and smooth muscle [Fig. 2, Nontumor tissues (NT), arrow
heads and large arrowheads in D, K, and N\. In all cases, a single
discrete focus of pericentrin staining was detected, typical of the
centrosome pattern in normal cells. A low level of diffuse staining was
sometimes detected in nontumor tissues, which most likely repre
sented the modest level of cytoplasmic pericentrin known to be
present in normal cells. The absence of pericentrin anomalies in the
many different types of nonneoplastic cells within tumor sections (for
example, proliferating and nonproliferating cells, epithelial and endo-
thelial cells, and so on) strongly suggests that this phenotype is tumor
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Tumor Nontumor
Fig. I. Low-magnification images of malignant
tumors showing amplified periccnlrin staining. Par
affin-embedded (issue sections were stained for
pericentrin by the immunoperoxidase method
(brown] and counterstained with hematoxylin
(blue] to reveal details of tissues and cells. Images
show a high level of pericentrin staining in tumor
tissue compared to nontumor tissue. A, breast ade-
nocarcinoma metastasi/ed to lymph node. B, lung
tumor in situ. Scale bar (in B), 20 jim (for both A
and B].
Tumor
Tumor
Nontumor
B
Tumor
related and does not simply reflect the stage of differentiation, differ
ences in cell type, or proliferation rate.
The presence of defective pericentrin structures in tumors was
significantly higher than in nontumor tissues (Table l, P < 0.0001,
two-sided Fisher's exact test). Although nontumor tissues appeared
normal in all cases, 93% of the tumors examined (81 of 87) showed
one or more defects. Up to 95% of the cells in some tumors exhibited
the abnormal phenotype. In some tumors, the abnormal phenotype
was not observed. This could reflect a lower stage of tumor progres
sion, the inability of our assay to detect subtle abnormalities in
pericentrin organization, or the lack of centrosome abnormalities in
these tumors. It appears that insensitivity of the archival tissue assay
may be partially responsible for the apparent lack of defects in some
tumors because pericentrin organization appeared to be more severely
perturbed in freshly isolated cells from a limited number of tumors
(n = 5; for example, see Fig. 3//). These data indicate that many
malignant tumors have higher levels of pericentrin and that pericentrin
is organized into atypical and supernumerary structures in the cyto
plasm of tumor cells.
Defects in Pericentrin Organization in Tumor-derived Cell
Lines. The observed defects in pericentrin organization in malignant
tumors were also found in permanent cell lines established from
tumors. These included cell lines derived from colon, breast, and
prostate and from patients with HD (Fig. 3). Using both immunoper
oxidase and immunofluorescence methods, we detected pericentrin
structures of abnormal size and shape (Fig. 3, A, arrows, B, and D-G)
and supernumerary structures (Fig. 3, A, arrowheads, and D-F). Over
25 centrosomes were detected in some tumor-derived cells (Fig. 3f),
and they varied in size from tiny flecks of material a fraction of the
size of normal centrosomes to large aggregates (Fig. 3, D and F) or
long linear arrays up to ten times larger than normal centrosomes (Fig.
3G). Diffuse cytoplasmic material was also observed in tumor cells
and was usually found together with other centrosome defects (data
not shown; see "Materials and Methods"). Up to 67% of the cells in
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Fig. 2. High-magnification images of malignant tumors showing abnormal pericentrin structures. Tissues were processed for pericentrin staining as in Fig. I. Cells in nontumor
tissues (AT), in the same tissue section as tumor cells (T), usually have a single small focus of staining, typical of normal centrosomes (large arrowheads, Nontumor tissues, and NT
in D, K, and N). Pericentrin-staining structures in tumor cells are usually larger in diameter (most panels) and often abnormal in number (A and D. small arrowheads). In addition, most
tumor cells contain increased levels of pericentrin within the cytoplasm (most panels). Occasionally, structures with abnormal morphology are observed (O. see linear elements at
arrowheads). Tissues were from the following: A-C, lymph node with metastatic breast tumor; D-G, lung; H-J, prostate; K-M, colon; N-P, brain. Nontumor tissues were from the
following: C. lymph node; D (NT), stroma in lung; /â€¢",alveolar wall; G, bronchial epithelium; J. prostate gland; K (NT), stroma in intestine; M, intestinal epithelium; N (NT), blood vessel;
P, brain white matter. AT, nontumor tissue; N, nucleus. All images are same magnification. Scale bar (in P), 10 /xm (for A-P).
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B
Fig. 3. Abnormal pericenirin structures in
tumor-derived cell lines (/t-O'l and cells dissoci
ated from tumors (H}. A. HD cell line (L428)
stained hy immunopcroxidase (as in Fig. II. show
ing several cells with enlarged pericentrin staining
structures (arrows) and multiple pericentrin stain
ing structures (iirrtwfit'iuls). H. enlargement of cell
in A. showing large pericentrin structure at center
of multiple nuclei. C. cell from a nonlumor cell line
(B21X) processed for immunofluorescence with an-
tipericentrin antibodies and showing a single dot
(red) next lo the nucleus (bliu-), typical of centro-
some staining in normal cells. Cells from breast
lumor cell lines (D. MDA-MB-157; F. BT-549I
and a prostate tumor cell line <Â£and G. PC-13)
showing multiple pericemrin staining structures (5
to >25|. In addition, the structures are variable in
si/.e (1) and /-'I. linked together by strands of neri-
centrin-staining material (Â¿'Iand organi/.ed into
string-like arrays (G. nucleus out of view). H. cell
dissociated from a human breast lumor showing
multiple fluorescent foci of pericentrin staining
(whiiflyt'llttw). Settle httrs. .10 p.m (si'tilv bar in G
for B-C. A and fi, immunoperoxidase labeling:
C-H, immunofluorcsccnce labeling. A-C. cell
lines: H, cell dissociated from tumor.
some tumor-derived lines had defective pericentrin structures,
whereas most cells from nontumor lines had single fluorescent dots of
uniform si/.e. typical of pericentrin staining in normal cells (Fig. 3C).
Statistical analysis demonstrated that the defects observed in all eight
tumor lines examined were significantly greater than those in nontu
mor cell lines (Table 2, all /'s <0.001. Pearson's \1 test). Nontumor
cells rarely exhibited multiple pericentrin foci. It is possible that
nontumor cells in both established lines and primary tumors exhibit a
Table I Ct-nlrosontc iihtwrmtiliiies in nuili^nunl Himors"
Abnormal
centrosomes''
Tumor type'
Breast Prostate- Brain Lung Colon
In tumor cells
In nontumor cells'
18/19
0/21
16/18
0/25
19/20
0/18
15/15
0/23
13/15
0/20
" For all samples in this analysis, paraffin-embedded tissues were sectioned, reacted with pericentrin antibodies and immunoperoxidase methods, and examined by light microscopy.
Defects in cenlrosomes were statistically higher in tumors as compared to nontumor cells. Statistical analyses were described in "Results" and "Discussion."
' C'entrosomes were considered abnormal if they had diameters >2 times the diameter of centrosomes in nonlumor control cells in the same section: if they lacked ccnlrioles; if
they were present in more than two copies per cell; or if they were organi/.ed into elongated structures >3 /un long, string-like elements, or large patchy aggregates. Most lumor cells
had more than one defect. Similar results were obtained by immunofluorescence analysis (data not shown).
Tumors were identified by architectural and nuclear cylological features on hemaloxylin-counlerstained immunoperoxidase preparations.
' Nontumor cells had none oÃ-the centrosome abnormalities described above. They were used as internal controls for each tumor and included stromal cells, lymphocytes, astroglia,
cndothclial cells, and mature nonneopla.stic epithelial cells present within the same tumor tissue sections. Centrosomes in nontumor cells were indistinguishable from those of normal
cells.
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Table 2 Aherranl i-entrt>M>nte\,nuclei, und chronwstittu' numÃ•H'rsin Iunior- und
nmi-lumor-ilerivetl cell linei"
Cells and celllines''Tumor-derived
celllines
HT-29
LovoHS578TBT-549MDA-MB-436L428KHM2JCNon-tumor-derivedcell
linesBI15
B21S
COS 7Tissue
oforiginColoreetal
ColoreetalBreastBreastBreastHDHDHDLymphoblastoid
Lymphoblasioid
Monkey kidneyAbnormal
cenlrosomes'24%
9%22%67%14%If.-;45%13%3%2%
0.3%Abnormal
Nuclei''12%
11%15%50%17';;26%29%11%2%
3%0.5%Chromosomal
instability(Chrl/ChrSr"57%/43%/
ND"/27%/66%/70%73%/72%36%/40%33%/29%37%/28%29%/29%6%/5%
7%/4%
ND
" Defects in centrosomes, nuclei, and chromosome number were all statistically higher
in tumor cells as compared to nontumor cells. Statistical analyses were performed asdescribed in "Results" and "Discussion."
'' Cell lines were described in "Materials and Methods."
1 The percentage of cells with three or more discrete pericentrin-staining foci, peri-
centrin structures without centrioles. long linear structures (>3 /xm long), and structures
much smaller (<509i) or larger (>300%) in diameter than in control cells. All cells were
examined by Â¡mmunofluorescence methods. At least 500 cells were counted for each cell
line. Values represent the average of three independent experiments. Similar results were
obtained by immunoperoxidase labeling (data not shown).
''The percentage of cells with nuclei exhibiting defects in morphology and/or size
(multiiobed or multinucleale). as observed by DAP1 staining. At least 300 cells were
counted for each cell line and values represent the average of two experiments.
' Percentages represent the fraction of cells with chromosome numbers that were
different from the mode (a gain or loss), as described (15). We used directly labeled
chromosome-specific centromeric probes to chromosome I (Chrl ) and chromosome 8
(Chr8). Between KM)and 150 cells were counted for each value, which is the average of
two staining reactions.
' Previously determined values for chromosomal instability (15).
* ND. not determined.
basal level of pericentrin abnormalities that is corrected through
appropriate cell cycle checkpoints or eliminated by activation of
appropriate apoptotic pathways (see Rets. 1 and 11).
Supernumerary Centrioles and Acentriolar Structures in
Tumor-derived Cell Lines. If the atypical pericentrin structures de
scribed above were centrosomes with normal architecture, they should
possess centrioles (see Ref. 7). To detect centrioles, cells were stained
with antibodies to a-tubulin following the selective depolymerization
of cytoplasmic microtubules with nocodazole (7, 19). To our surprise,
centrioles in tumor cells were sometimes absent from pericentrin
structures, especially those of variable size and irregular shape (Fig. 4,
C and D, large arrowhead). However, pericentrin structures of normal
size and morphology usually had centrioles, even when they were
present in multiple copies in the cytoplasm of tumor cells (Fig. 4, E
and F) and cells dissociated from fresh tumors (data not shown).
Control cells typically had a pair of centrioles at the focus of peri
centrin staining, as expected for normal cells (Fig. 4, A and B).
Quantitative analysis showed a good correlation between centrioles
and pericentrin foci in control cells (100%, n = 214), whereas
centrioles were absent from pericentrin structures in a significant
percentage of cells in a breast line (11.2%, n = 223, BT-549), a HD
line (14.1%, n = 227, L428), and others (data not shown). This
demonstrates that, although many pericentrin-staining structures ob
served in tumors and tumor-derived cell lines are canonical centro
somes, a proportion of them lack centrioles. Because pericentrin is
found in centrosomes and other MTOCs that lack centrioles (19), we
examined all pericentrin structures in tumor cells for the ability to
nucleate microtubules.
All Pericentrin Structures in Tumor Cell Lines Nucleate Mi
crotubules. To test for microtubule nucleation, cells were treated
with nocodazole to depolymerize microtubules and were washed free
of the drug to allow microtubule regrowth from centrosomes. Under
these conditions, essentially all pericenlrin foci nucleated the growth
of new microtubules regardless of their number, size, morphology,
and the presence of centrioles (Fig. 5). Even the smallest detectable
specks of material (Fig. 5, C and E) and the long linear arrays (Fig.
5G) nucleated microtubules (Fig. 5, D, F. and H). These additional
MTOCs significantly increased the nucleating capacity of tumor cells
compared to control cells, in which a single centrosome (one or two
dots) nucleated a single microtubule aster (Fig. 5, A and B). The
presence of multiple MTOCs suggested that tumor cells might form
abnormal spindles during cell division.
Defects in Mitotic Spindle Organization and Chromosome Seg
regation in Tumor Cell Lines. Spindle defects were observed in
cells of all tumor-derived lines (Fig. 6) and cells freshly dissociated
from tumors (data not shown). Although control cells had a typical
bipolar spindle with a single pericentrin focus at each pole (Fig. 6,
A-O, tumor cells often had misshapen spindles and spindles with
poorly focused poles or multiple poles (Fig. 6, E, H. K, and AO.Most
abnormal spindles were associated with pericentrin structures that
were aberrant in number (Fig. 6, D-F, G-I, and M-O), shape (Fig. 6,
M-O), and orientation (Fig. 6, D-F, G-I, and J-L).
In many tumor cells, unequal numbers of chromosomes were
aligned between multiple poles of abnormal spindles (Fig. 6, / and O).
and they appeared to be missegregated as cells divided (Fig. 7). We
often observed telophase cells undergoing multipolur divisions and
segregating their genomes unequally into more than two progeny (Fig.
7, A and B). In other telophase cells, chromosomes appeared to remain
at the metaphase plate after others had been segregated to the poles
(Fig. IE, arrow) or they segregated part way but did not appear to be
included in reforming nuclei (data not shown). Abnormalities in
spindle organization and function were detected in up to 36% of
mitotic cells in some tumor cell lines (for example, BT-549. Â»= 143).
These observations demonstrate that defects in pericentrin organiza
tion, spindle structure, and chromosome segregation often occur to
gether in the same tumor cell, and they suggest that centrosome and
spindle defects contribute to abnormal partitioning of chromosomes.
To obtain a more accurate measure of chromosome missegregation.
we examined the copy number of individual chromosomes in tumor
cells.
CIN and Nuclear Abnormalities in Tumor Cell Lines. To assay
for CIN in tumor cells, we examined chromosomes in individual
cells by FISH (24) using probes for chromosomes 1 and 8. In all
malignant tumor cell lines examined, we found a dramatic varia
bility in chromosome copy number among individual cells in the
population. One such example is shown in Fig. 8, where the
frequency distribution of chromosomes I and 8 in a malignant
breast carcinoma cell line (Fig. 8, C and D. BT-549) clearly
demonstrates a highly variable number of chromosomes per cell. In
contrast, a nontumorigenic cell line (Fig. 8. A and B, B115) has
only two copies of each chromosome in most cells. The variability
in chromosome number observed in tumor cells has recently been
termed CIN (15) and is thought to result from chromosome mis-
segregation during mitosis. Over 70% of the cells in some lines
exhibited CIN of chromosomes 1 and 8. with copy numbers rang
ing from 1 to 22 per cell (Fig. 8 and Table 2). The level of CIN in
all tumor cell lines examined (27-73%) was statistically higher
than that in control cells (Table 2: 4-7%, P < 0.001, Pearson's *2
test). Control cells used in this study had CIN levels similar to
those of uncultured lymphocytes and to those used in other studies
(15) and, thus, appeared to represent the intrinsic error rate of the
FISH methodology. Despite the fact that the number of tumor cell
lines used in this analysis was low (Â»= 8). we found a positive
correlation between abnormal pericentrin organization and insta-
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Fig. 4. Supernumerary cenlrioles and acentriolar
structures in tumor-derived cell lines. Cenlrioles
were labeled with an u-tubulin antibody following
depolymeri/ation of cyloplasmic microlubules by
nocodazole (see "Malcriais and Methods"). Hori-
/ontal series are of the same cell in all cases. In
control cells (BII5). a pair of centrioles (B) is
found M the focus of pcricenlrin staining (A). In the
HD cell line (L428) the (wo separated centrioles
(D. iirnwht'(uls) arc coincident with some pericen-
trin staining foci (C*. snuill arnwheads) but not
with others (C, large arrowhead}. A cell from a
breasl tumor cell line (BT-549) with multiple foci
of pericentrin staining is shown in E. each coinci
dent with ceninole staining (F). A few microlu
bules that were incompletely dcpolymerized are
presenl in F. Scale bar (in D, 10 (im (for A-F).
bility of chromosome 1 (P < 0.05, Spearman's rank correlation) DISCUSSION
but not chromosome 8 (P = 0.204, see "Discussion"). In addition,
aberrant nuclei (multilobed or multinucleate) were observed in all
tumor cell lines (Fig. 3, E and F, and Table 2), and their presence
correlated with abnormal pericentrin organization (P < 0.001,
Pearson's ^2 test). Taken together, these results indicate that
centrosome defects and CIN occur together in most malignant
tumor cell lines.
Using immunoperoxidase and immunotluorescence labeling
techniques and antibodies to pericentrin, we have identified wide
spread defects in centrosomes in the most common human malig
nant tumors and tumor-derived cell lines. These tumor cells mis-
segregate chromosomes on aberrant mitotic spindles and exhibit
variability in chromosome number. Given the important role of
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Fig. 5. All pericenlrin-staining material nucleates microtubules. Cells from the control eell line Bl 15 l.-\ and /ft and breast caneer-derived cell lines. IÃŒT-54M(C. li. (i. and /f) and
MDA-MB-436 (E and F) were treated with nocodazole to depolymerize microtubules. washed, and allowed to regrow microtubules. Cells were triple-labeled for pericenlrin (red or
yellow), microtubules (green), and DNA (blue). All foci of pericentrin staining (A, C, Â£,and G) nucleated the growth of microtubules (B. D. F. and H). Even the very small foci seen
in C, E, and G and the atypical elongated elements in G nucleated microtubules (D. F. and H). Insel (in H). higher magnification of region at arrow. All ectopie nucleating centers
are in a single cell as determined by phase contrast microscopy (data not shown). A. C. E. and G. pericentrin staining; B. D. F, and H. triple-channel overlay showing pericentrin (vellow),
microtubules (green), and DAPI (blue). Scale bar (in H). 10 /Â¿m(for A-H). Horizontal series (A and B, C and D: Â£and F; C and W) are of the same cell.
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Fig. 6. Abnormal |H'iicentrin structures arc associated with aberrant spindles. Control cell (Bl 15) with two centrosomes (A) at the poles of a normal bipolar spindle (B) and DNA
aligned on the metaplusc plate id. Abnormal pericentrin structures and spindle detects in cell lines derived from a breast tumor (BT-549. /)-/), a prostate tumor (PC-I3, J-L). and
an individual with HD iM O). ( VIis with pericentrin structures of variable si/.es. shapes, and numbers participate in the formation of multipolar spindles ((/', //. M. and AOand spindles
with unfocused or misshapen poles (D. E, J. and K). Some pericentrin structures do not locali/.e to the poles of aberrant spindles (D. E, (Ã¬.and //). A. D. G. and J. pericentrin structures;
B, E, H, and K, mierolubules; and C. F. I. and L. DNA. Horizontal series (A-C; D-F; C-l; J-L) are of the same cell. Scale bars. 10 /Â¿m(scale bar in C for A-C. in L for D-L; in
O. for M-O).
centrosomes in mitotic spindle organization, it is possible that
centrosome delects contribute to this CIN and, ultimately, to the
neoplastic phenotype.
Although tumor cells derived from different tissue sources have
defects in different biochemical pathways (25), it is remarkable that
nearly all malignant tumors examined in this study exhibited abnormal
centrosomes. Abnormal centrosome features included structural defects,
the absence of centrioles, elevated levels of pericentrin staining, super-
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Fig. 7. Aberrant spindles misseuieyate chromosomes. A telophase cell from the prostale cancer cell line lPC-I3l srumini! a tripolar spintile l/il \\ilh three spindle poles I.K suine
with multiple pericentrin structures (A. hialina left and tup righli. Chromosomes are segregated into three naseent daughter cells (ÃŸ:note midhodies. the remnants of the spindlel.
Another telophase cell from a breast eancer cell line (BT-549. C-E} with multiple eentrosomes at both poles (C) and typieal midbody staining of microtubules (D) is shown.
Missegregated ehromosome(s) remain between reforming nuclei of daughter eclts (Â£.arrow), (jreen/wlltw. eentrosomes: ml. microluhules: hint1, DNA. A. superposition of
eentrosomes and niierotubules: B. superposition of mierotuhules and DNA. fiar (in Â£).10 jam (for A-E). Horizontal series (A and B: C-E) are of the same cell.
numerary structures, and increased microtubule nucleation. In contrast,
eentrosomes in nontumor cells were consistent in size, shape, and number
and indistinguishable from those of other normal cells (19). These ob
servations clearly demonstrate that the centrosome-defective phenotype is
tumor related.
The presence of centrosome detects correlated remarkably well
with chromosome instability because both were significantly higher in
tumor versus nontumor cells (P < 0.001. Pearson's \1 test). Further
more, we often observed missegreguted chromosomes and defective
eentrosomes in the same mitotic cells, suggesting a direct relationship
Chromosome 1 Chromosome 8
Fig. 8. CIN in tumor and nontumor cell lines.
Frequency distribution of chromosomes I (A and
O and 8 (B and D] in a control cell line IBI I5. A
and ÃŸ)and in the breast cancer cell line (BT-549. C
and D). as determined by quantitative analysis of
cells stained by FISH. The copy number of chro
mosomes I and 8 are different from the mode in
-70% of the cells in BT-549 and <5<i in Bl 15.
BUS. mode = 2 for both chromosomes; BT-549.
mode = 4 for chromosome I and mode = 5 for
chromosome 8.
12345678 91011
Copy number/Cell
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between these two cellular anomalies. In addition, we observed a
statistically significant correlation between the level of centrosome
delects and the level of chromosome 1 instability in tumor cells(P < 0.05, Spearman's rank correlation).
Although these data show a correlation between centrosome defects
and CIN in tumor cell lines, they do not demonstrate that centrosomes
play a direct role in the generation of CIN. Perhaps the most com
pelling data supporting a role for centrosomes in this process comes
from transient transfection experiments showing that overexpression
of a single centrosome protein (pericentrin) induces the formation of
abnormal centrosomes. assembly of disorganized spindles and varia
bility in chromosome numbers (CIN: Ret. 26). These aberrant features
of pericentrin overexpressing cells are strikingly similar to those
observed in malignant tumor cells. We are currently analyzing the
pericentrin overexpressing cells for tumorigenic properties in vitro
and in vivo (27-29).
It is easy to envision how a primary centrosome defect could
contribute to CIN and, perhaps, to the development of the neoplastic
phenotype. We propose a model in which centrosome defects alter the
normal assembly, organization, and function of mitotic spindles, lead
ing to the missegregation of chromosomes. These events could result
in gains and losses of chromosomes that, together with the growth-
selection pressure that tumors experience, provide a mechanism by
which cells could accumulate tumor-promoting genes (activated on-
cogenes) and lose normal copies of tumor suppressor genes. Cells
with these genetic defects would be predisposed to the acquisition of
additional genetic lesions that could lead to the malignant neoplastic
phenotype (1. 15). If centrosome defects are involved in tumorigen-
esis, they should appear early in tumorigenesis. We are currently
examining early-stage cancers for centrosome anomalies.
The ability to induce chromosome instability through the artificial
elevation of pericentrin (and perhaps other centrosome proteins) raises
the possibility that a similar mechanism may be operating in tumor
cells. Consistent with this idea is the universally higher levels of
pericentrin staining observed in malignant tumors. Assembly of this
excess protein could induce the formation of the ectopie microtubule
nucleating centers and aberrant mitotic spindles that are commonly
observed in tumor cells. Assembly of these multiple atypical MTOCs
could occur without invoking multiple rounds ot centriole duplication
( 18) because structures that lack centrioles and retain the capacity to
nucleate and organi/e microtubules are found in cells of many organ
isms (30-33).
The centrosome defects observed in tumor cells could also arise
indirectly through disruption of other cellular processes such as cy
tokinesis or through abrogation of cell cycle regulatory pathways such
as cell cycle checkpoints that allow mitosis to proceed even when
DNA is damaged or when chromosomes are improperly aligned on
the spindle (see below: Refs. 1, 2, 9-11, and 34). Although cytoki
nesis failure may occur in some tumor cells, we believe that it cannot
account for the centrosome defects observed in this study. Multiple
rounds of failed cytokinesis should produce cells with structurally
normal centrosomes, the numbers of which reflect multiple doublings
(2 to 4 to 8, and so on; Ref. 35). However, centrosomes in tumor cells
were highly variable in number and had numerous structural defects.
Furthermore, cells that fail in cytokinesis should exhibit strict dupli
cations of the genome (tetraploid, octaploid, and so on) rather than the
enormous variability in chromosome number observed in this study
(Fig. 8). These observations indicate that cytokinesis failure alone is
insufficient to explain the defective centrosome phenotype observed
in tumor cells.
Little is known about how the mammalian centrosome duplicates
and assembles to form a functionally mature organelle. Results
from embryonic systems have shown that centrosome duplication
and assembly continues when the cell cycle is blocked (36, 37) and
when DNA replication is arrested (7, 35). However, recent work
suggests that the centrosome duplication cycle may be controlled
by the tumor suppressor gene p53, which is involved in regulating
cell cycle checkpoints at both G,-S and G2-M (18, 38, 39). In
addition, other genes are likely to control this process (see Refs. 7
and 30). It does not appear that the centrosome abnormalities
observed in this study result from abrogation of p53 function
because some cancer cell lines used in our analysis (Lovo) exhibit
centrosome defects and CIN but have normal levels of functional
p53 (15). Duplication of centrioles in mammalian cells and the
spindle pole body in yeast begins around the time of the G,-S
transition (start, restriction point: see Refs. 7 and 30). Although the
regulatory pathways that control this transition are likely to play a
role in centriole duplication in mammalian cells, it is not until late
in G, that two functionally active centrosomes appear. This sug
gests that additional regulatory controls are involved in the assem
bly and functional maturation of centrosomes. A more detailed
analysis of the centrosome-defective phenotype in malignant tu
mors using high-resolution microscopy (40) and other methods
may provide insights into the mechanisms of centrosome assembly
and maturation and may also provide a better understanding of the
relationship between centrosome defects and chromosome misseg
regation in cancer.
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Note Added in Proof
Similar centrosome defects were recently described in breast carcinoma (W. Lingle,
W. H. Lutz, J. Ingle. N. J. Maihle. and J. L. Salisbury, Proc. Nati. Acad. Sci. USA, 95:
2950-2955. 1998.)
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